PAR Equity Snapshot

IPN Weekly Equity Report

Ipsen S.A.

Interactive chart JSON snapshot
Latest Close 157.8 EUR 12 Jun 2026
1W Return 0.0% latest completed week
4W Return -3.9% short-term follow-through
12W Return 5.5% quarterly tape
Trend Breadth 80.8% 42 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to …

Snapshot

What the weekly tape is saying

IPN closed the latest completed week at 157.8 EUR. The 4-week return is -3.9% and the 12-week return is 5.5%. Trend Signal is active, Market Dynamics is -0.53. Setup signature: Balanced read with a 56/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 7.6%
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 89 Persistence of active Trend Signal over the last year and current streak.
Momentum 46 Blend of 4-week and 12-week follow-through.
Dynamics 0 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 90 Relative leadership and short-term RS change.
Volume 41 Participation compared with the 13-week volume baseline.
Risk Control 70 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
146.7 EUR
Vs Trend Line
7.6%
Fair Value
116.6 EUR
Vs Fair Value
35.4%
52W High
171.7 EUR
52W Low
100.2 EUR
Drawdown
-8.1%
Range Position
80.6%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.0%
4W -3.9%
12W 5.5%
26W 30.3%
52W 52.8%

Trend read

Active Streak
42 weeks
52W Active Weeks
42
52W Active Breadth
80.8%
Sector Scope
FR Healthcare
Sector Rank
24 of 76
Sector Percentile
69.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.53
4W MD Change
-510.3%
Relative Strength
14.61
4W RS Change
-49.3%
Expectation
Undecided
Probability
46.25%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
573.9K
13W Average
590.5K
52W Average
452.8K
Vs 13W
1.0x
Vs 52W
1.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.0%
52W Volatility
3.9%
Upside Weeks
27
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
3.7% / -2.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
PAR
Country
FR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
EUR
Market Cap
12.7B

Opportunity signals

  • Trend Signal is active with a 42-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 157.8 EUR 0.0% 146.7 EUR 116.6 EUR -0.53 14.61 573.9K On
5 Jun 2026 157.8 EUR 1.8% 145.8 EUR 116.3 EUR -0.40 17.20 658.8K On
29 May 2026 155.0 EUR -2.2% 144.7 EUR 115.9 EUR -0.25 16.38 933.4K On
22 May 2026 158.5 EUR -3.5% 143.6 EUR 115.6 EUR -0.09 20.86 651.5K On
15 May 2026 164.3 EUR -0.2% 142.3 EUR 115.3 EUR 0.13 28.82 451.8K On
8 May 2026 164.7 EUR -0.4% 140.7 EUR 115.0 EUR 0.41 27.77 488.9K On
1 May 2026 165.2 EUR 2.5% 139.1 EUR 114.6 EUR 0.79 29.34 503.5K On
24 Apr 2026 161.3 EUR 0.7% 137.4 EUR 114.2 EUR 1.00 26.69 622.4K On
17 Apr 2026 160.1 EUR -5.3% 135.8 EUR 113.9 EUR 1.09 22.82 686.3K On
10 Apr 2026 169.0 EUR 2.0% 134.3 EUR 113.5 EUR 1.12 33.37 546.3K On
3 Apr 2026 165.7 EUR 5.1% 132.6 EUR 113.1 EUR 1.05 36.93 453.0K On
27 Mar 2026 157.7 EUR 5.4% 131.1 EUR 112.7 EUR 1.14 35.87 441.5K On
20 Mar 2026 149.6 EUR -1.8% 129.7 EUR 112.3 EUR 1.46 30.68 664.8K On
13 Mar 2026 152.3 EUR -5.3% 128.6 EUR 112.0 EUR 1.64 29.89 611.3K On